Your browser doesn't support javascript.
loading
α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease.
Magenau, John M; Goldstein, Steven C; Peltier, Dan; Soiffer, Robert J; Braun, Thomas; Pawarode, Attaphol; Riwes, Mary M; Kennel, Maggi; Antin, Joseph H; Cutler, Corey S; Ho, Vincent T; Alyea, Edwin P; Parkin, Brian L; Yanik, Gregory A; Choi, Sung Won; Lewis, Eli C; Dinarello, Charles A; Koreth, John; Reddy, Pavan.
Affiliation
  • Magenau JM; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
  • Goldstein SC; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
  • Peltier D; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
  • Soiffer RJ; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Braun T; Department of Biostatistics, University of Michigan, Ann Arbor, MI.
  • Pawarode A; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
  • Riwes MM; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
  • Kennel M; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
  • Antin JH; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Cutler CS; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Ho VT; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Alyea EP; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Parkin BL; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
  • Yanik GA; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
  • Choi SW; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
  • Lewis EC; Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva, Israel; and.
  • Dinarello CA; Department Medicine and Immunology, University of Colorado, Aurora, CO.
  • Koreth J; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Reddy P; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
Blood ; 131(12): 1372-1379, 2018 03 22.
Article in En | MEDLINE | ID: mdl-29437593
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Alpha 1-Antitrypsin / Graft vs Host Disease Type of study: Clinical_trials / Observational_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2018 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Alpha 1-Antitrypsin / Graft vs Host Disease Type of study: Clinical_trials / Observational_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2018 Type: Article